missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Talquetamab Humanized Recombinant Human Monoclonal Antibody
Talquetamab Recombinant Monoclonal Antibody
Marca: Invitrogen™ MA560130
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Talquetamab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional
Talquetamab (JNJ-64407564) is a bispecific antibody that targets CD3, which is expressed on T-cells, and GPRC5D, which is highly expressed in multiple myeloma cells. Talquetamab (JNJ-64407564) is being investigated in a Phase 1 clinical study to treat relapsed or refractory multiple myeloma.
Especificaciones
| Talquetamab Humanized | |
| Recombinant Monoclonal | |
| Unconjugated | |
| JNJ-64407564 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG4 |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 1 mg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction